December #97 : Breaks: What’s Up? - by Tim Murphy

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Born Again

Knowing When to Stop

The Divine Miss Em

Alcohol

Cocaine & Heroin

Crystal Meth

Harm Reduction

Sex

Recovery Rooms

Touchdown

A for Africa

Earthwatch

WHO’s on First

Dying for ADAP

Milestones

Bombing Gilead

Pos & Neg

Wishful Thinking

Unwrapper’s Delight

Study Hell

Tech Talk

Briefs

Diarrhea Diary

HAART to Heart

Eradication II?

2/3

Breaks: What’s Up?

Safe Spliffs

Slumber Party

Bone Loss

Gimme Shelter

Adherence

IRSA’s Rochelle advises HIVer refugees:

Editor's Letter

Mailbox

Sale of a Lifetime



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2003

Breaks: What’s Up?

by Tim Murphy

The latest studies send mixed messages on the pros and cons of drug breaks (strategic treatment interruptions, or STIs). Here’s our four-point guide to sorting them out:

CD4 counts count. The higher your CD4s before you went on meds, the better you’ll do off them, say two recent Italian studies. They found that HIVers with pre-HAART CD4 counts between 200 and 500 coasted safely for well over a year med-free. Where does that leave us pill-weary folks who started lower? Read on.

Proceed with caution. In studies, HIVers whose lowest pre-HAART CD4 count had been below 200 quickly dropped back down there when they went off meds. But HIV pro Judith Feinberg, MD, says “sometimes breaks are what my patients need,” so she monitors their CD4s closely and warns as they near the red zone.

No rest for the weary. HIVers fed up with a failing “salvage” regimen may yearn for a break, but research into whether STIs can actually boost their immune systems looks like “a dead duck,” says Florida’s Gerald Pierone, MD. Indeed, most docs agree it’s safer to stay on meds. Still, a San Francisco study suggests that “partial” breaks (stopping the protease inhibitors and staying on the NRTIs) may steady salvagers while saving for later what protease punch is left.

The seven-day itch. HIVers switching between one week on/one week off meds have shown mixed results in suppressing viral load. Pierone says the strategy might work best with a combo of Viread, Emtriva and Sustiva (all last long in your body)—but more study is needed. He adds that five days on/two days off “makes more sense.” We add: Talk to your doc before you slam on any breaks.




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    slimcuteguy
    Asheville
    North Carolina


    Heartland4now
    Tacoma
    Washington


    clintonjrsyr
    syracuse
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.